United States
Germany
Japan
United Kingdom
China
LRRC25 mouse monoclonal antibody, clone OTI1D9 (formerly 1D9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
LRRC25 mouse monoclonal antibody, clone OTI2A3 (formerly 2A3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI3E4 (formerly 3E4)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1A2 (formerly 1A2)
| Applications | FC, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI3B6 (formerly 3B6)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1C5 (formerly 1C5)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1B3 (formerly 1B3)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1D9 (formerly 1D9)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI2A3 (formerly 2A3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI3E4 (formerly 3E4)
| Applications | FC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1A2 (formerly 1A2)
| Applications | FC, IHC, WB |
| Reactivities | Human |
LRRC25 mouse monoclonal antibody, clone OTI1C5 (formerly 1C5)
| Applications | FC, WB |
| Reactivities | Human |
